Saturday 17 October 2026 Export RGEN’s income statement to Excel — free account

Repligen Corporation

RGEN Healthcare Medical Instruments & Supplies

Repligen Corporation’s revenue for fiscal 2025 (year ended December 2025) was $738.3 million, up 16.4% from fiscal 2024. In the quarter to June 2026, revenue grew 11.9%, EPS fell 65.4%, free cash flow grew 27.1% and total debt rose 3.25%, each against the same quarter a year earlier.

175.20 8.97 −4.87%

Follow RGEN

Alert me

Market cap: $11.7B
P/E: 234×
Fwd P/E: 112×
Dividend yield: —
F-score: 6/9
Altman Z: 7.49
Beneish M: −2.52
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Repligen Corporation (RGEN) P/E ratio

Alert me on P/E ratio

As of 16 October 2026, Repligen Corporation (RGEN) trades at a P/E ratio of 234×. Over the past ten years it has ranged from 0.0× (September 2025) to 5,725× (November 2025); the current reading is higher than 87% of that period. That is above the Medical Instruments & Supplies industry median of 33.8× and above the Healthcare sector median of 23.0×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/RGEN/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Repligen Corporation P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/RGEN/metrics/pe-ratio">Repligen Corporation (RGEN) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	188×	—
FY2024	0.0×	—
FY2023	268×	454.85%
FY2022	48.2×	(57.40%)
FY2021	113×	(32.67%)
FY2020	168×	(18.22%)
FY2019	206×	48.11%
FY2018	139×	173.38%
FY2017	50.8×	(42.96%)
FY2016	89.0×	(8.77%)

Period	P/E ratio	Change
Jun 2026	182×	42.05%
Mar 2026	128×	(32.00%)
Dec 2025	188×	(95.77%)
Sep 2025	4,456×	—
42 more quarters	Free account

Against its own ten years

Low 0.0× High 5,725×

Ten-year median 113×

Current reading's percentile 85

Company	P/E ratio
BAX Baxter International Inc. compare	n/m
BLCO Bausch + Lomb Corporation compare	n/m
AVTR Avantor, Inc. compare	n/m
TFX Teleflex Incorporated compare	n/m
SOLV Solventum Corporation compare	10.4×
COO The Cooper Companies, Inc. compare	19.8×
ATR AptarGroup, Inc. compare	22.2×
ALGN Align Technology, Inc. compare	25.6×
RGEN Repligen Corporation	234×
Medical Instruments & Supplies industry median	33.8×
Healthcare sector median	23.0×
Market median	18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Repligen Corporation (RGEN) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on RGEN

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on RGEN

Stockrow Weekly